This is a news story, published by BBC, that relates primarily to The National Pharmacy Association news.
For more drug discoveries news, you can click here:
more drug discoveries newsFor more news from BBC, you can click here:
more news from BBCOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Ozempic. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest medication online news, pharmaceutical company Novo Nordisk news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
National Pharmacy AssociationBBC
•59% Informative
Ozempic is a brand of semaglutides which help people with type 2 diabetes regulate blood sugar levels.
Currently there is a shortage of the drug due to high demand and some doctors prescribing it off-label.
This has led to an increase in counterfeit jabs, which can be dangerous.
The National Pharmacy Association (NPA) is urging people to speak to a pharmacist or GP instead of online.
VR Score
50
Informative language
44
Neutral language
33
Article tone
formal
Language
English
Language complexity
61
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links